Literature DB >> 7288170

Outcome of asymptomatic infection with rubella virus during pregnancy.

J E Cradock-Watson, M K Ridehalgh, M J Anderson, J R Pattison.   

Abstract

We have tried to detect prenatal infection in 34 infants whose mothers were re-infected with rubella virus during pregnancy and in six infants whose mothers had primary subclinical rubella during pregnancy. Two methods of assessment were used: first, serum obtained soon after birth was tested for IgM antibody; secondly, serum obtained after the age of 8 months was tested for specific IgG. The 34 women with re-infections had increases in IgG antibody titre but no IgM response. No evidence of prenatal infection was found in 33 of their 34 infants. One infant was found to have IgG antibody at the age of 11 months. This infant was IgM-negative at birth and had a rubelliform rash at the age of 5 1/2 months; it therefore probably contracted post- rather than pre-natal infection. Fetal infection from maternal re-infection during pregnancy is probably rare. The six women with primary subclinical rubella produced both IgG and IgM classes of antibody. Three of their six infants showed serological evidence of intrauterine infection. One, infected when its mother was 8 weeks pregnant, had clinical evidence of congenital rubella. Primary subclinical rubella during pregnancy therefore carries a significant risk of fetal infection. Because of the difference in outcome, great care should be taken to distinguish between primary infection and re-infection when investigating symptomless increases in antibody titre after contact with rubella during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288170      PMCID: PMC2134037          DOI: 10.1017/s0022172400069345

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  18 in total

1.  Prospective studies of a group of Yale University freshmen. II. Occurrence of acute respiratory infections and rubella.

Authors:  A S Evans; J C Niederman; R N Sawyer
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

2.  Reinfection with rubella in pregnant women.

Authors:  A Boué; A Nicolas; B Montagnon
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

3.  A study of rubella immunity and resistance to infection.

Authors:  W J Davis; H E Larson; J P Simsarian; P D Parkman; H M Meyer
Journal:  JAMA       Date:  1971-01-25       Impact factor: 56.272

4.  Clinical and serologic studies of an outbreak of rubella in a vaccinated population.

Authors:  T W Chang; S DesRosiers; L Weinstein
Journal:  N Engl J Med       Date:  1970-07-30       Impact factor: 91.245

5.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

6.  Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.

Authors:  J Wilkins; J M Leedom; B Portnoy; M A Salvatore
Journal:  Am J Dis Child       Date:  1969-08

7.  Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero.

Authors:  L Z Cooper; R H Green; S Krugman; J P Giles; G S Mirick
Journal:  Am J Dis Child       Date:  1965-10

8.  Rubella syndrome after inapparent maternal illness.

Authors:  G B Avery; G G Monif; J L Sever; S L Leikin
Journal:  Am J Dis Child       Date:  1965-10

9.  IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1972-09

10.  Clinical and serological assessment of children exposed in utero to confirmed maternal rubella.

Authors:  C S Peckham
Journal:  Br Med J       Date:  1974-02-16
View more
  24 in total

1.  Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.

Authors:  J Gutiérrez; M J Rodríguez; F De Ory; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Rubella reinfection.

Authors:  E Miller
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  Congenital rubella infection after previous immunity of the mother.

Authors:  H Saule; G Enders; J Zeller; U Bernsau
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 4.  Rubella in the United Kingdom.

Authors:  E Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 5.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

6.  Rubella susceptibility and the continuing risk of infection in pregnancy.

Authors:  C L Miller; E Miller; P A Waight
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

Review 7.  Diagnosing rubella.

Authors:  P Morgan-Capner
Journal:  BMJ       Date:  1989-08-05

8.  Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM.

Authors:  K Bellamy; J Hodgson; P S Gardner; P Morgan-Capner
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

9.  Congenital rubella syndrome after maternal reinfection.

Authors:  B Weber; G Enders; R Schlösser; B Wegerich; R Koenig; H Rabenau; H W Doerr
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

10.  Specific IgG subclass antibody in rubella virus infections.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.